How do somatic cells and their proteins interact with SARS-CoV-2 when they are infected by the virus? Young scientists have now published the world's first publication on this subject. Mathias Munschauer, one of the lead authors, explains how this could lead to new treatment approaches.

Stress, anxiety and depression are on the rise in the Corona pandemic. To protect the mental health of people, families and sufferers, we need social exchange, creative ideas and more courage.

Experts estimate that up to 70 percent of COVID-19 patients suffer from smell and taste disorders. We spoke with Kathrin Ohla from the Jülich Research Center about an underestimated symptom.

Whether at school, kindergarten, the cinema, restaurant or at the doctor's office: Wherever many people gather inside, the risk of infection is particularly high. Researchers are therefore developing ventilation systems to reduce the uncontrolled spread of aerosols contaminated with viruses and bacteria.

The lockdown in spring changed the well-being of the Germans: Stress, fear and depressive symptoms increased. This is shown by the results of the NAKO health study. A conversation with the head of the study, Annette Peters from Helmholtz Zentrum München.

What will happen with the coronavirus pandemic in the coming months? Forschungszentrum Jülich, together with the Frankfurt Institute for Advanced Studies, has calculated various scenarios. In an interview, Jan Fuhrmann explains what the prospects are and what is important.

Approval for the first vaccine against SARS-CoV-2 is approaching. But there will not be enough vaccine doses for everyone. How the vaccination is regulated in Germany and which groups of people should receive the vaccine first.

Fabian Theis uses artificial intelligence to unlock the secrets of human cells. In the Corona Pandemic, he was able to help decipher how viruses work in the body

Antibodies could become an important weapon in the fight against SARS-CoV-2 infection. However, no therapy has yet been officially approved.